FAQ
Log In
Friday 15th December 2017
News
 › 
 › 

AstraZeneca sales fall

25th October 2012

Latest figures from AstraZeneca show that company’s sales dropped by a bigger-than-expected 19% in the third quarter.

Analysts say that the figures underscore the challenges facing the company’s new chief executive, Pascal Soriot, who joined from Roche on October 1. AstraZeneca is faced with patent expires on once best-selling medicines and has a thin pipeline of new drugs, meaning Soriot will need to re-focus operations and step up the hunt for acquisitions. Soriot has told reporters that buying in products would be an important way of rebuilding the pipeline.

 

Share this page

Comments

There are no comments for this article, be the first to comment!


Post your comment

Only registered users can comment. Fill in your e-mail address for quick registration.

Your email address:

Your comment will be checked by a Healthcare Today moderator before it is published on the site.

Article Information

Title: AstraZeneca sales fall
Author: Mark Nicholls
Article Id: 23034
Date Added: 25th Oct 2012

Sources

Yahoo News

Recent Related Articles

Prevention of inpatient falls has improved

Exercising could prevent elderly falls

Data on how much NHS trusts have made from land sales

Actions

Add to scrapbook
Show Comments
Add comment
Find all related articles

Tags

M3 - For secure managed hosting over N3 or internet
© Mayden Foundation 2017